Abstract:Stress proteins or heat shock proteins (hsps) are a group of families of approximately two dozen proteins and cognates showing highly homologous sequences between different species, from bacteria to man. Increased hsp expression, induced by different types of stress, such as infections, high temperature, free radicals or mechanical stress, provides the cells with protection from environmental insults [1–3]. Endothelial cells, macrophages and smooth muscle cells localized in atherosclerotic lesions express hsp at high levels [4], which is subjected to various stresses. Interestingly, hsp60, recognized as a mitochondrial protein, was identified as appearing on the cell surface [5,6]. It has also been demonstrated that hsp60 is present as a soluble form in circulation and correlated with severity of atherosclerosis [7,8] There is evidence that both chlamydial and human hsp60 have a cytokine-like activity and induce tumour necrosis factor- (TNF-) alpha and matrix metalloproteinase (MMP-9) production by human and mouse macrophages [9,10]. Importantly, both chlamydial or human hsp60 induced E-selectin, ICAM-1, and VCAM-1 expression and IL-6 production on endothelial cells [11]. These findings suggest that hsp60 directly stimulates vascular endothelial cells and macrophages, leading to an inflammatory response, which could contribute to the pathogenesis of atherosclerosis. In this issue of European Journal of Clinical Investigation, Prohaszka and colleagues [12] provide novel data that indicate an even stronger correlation between autoantibodies against human hsp60 and atherosclerosis, although a difference in anti-mycobacterial hsp65 or GroEL antibody titers between healthy donors and patients with severe atherosclerosis exists. What can we learn from such studies about the pathophysiology of atherosclerosis? Growing evidence indicates associations between infections and vascular disease [13]. How infections are involved in vascular disease remains to be elucidated. Increased blood viscosity, hypercoagulability and alterations of the serum lipid profile are postulated mechanisms. C.pneumoniae, H.pylori or cytomegalovirus infections may contribute to local inflammation by cytokine induction or antigen stimulation [13]. However, immune reactions to bacterial hsp65 may be a possible link between the various incriminated microorganisms and atherogenesis [14]. Abundant bacterial hsp65 may evoke an anti-self immune response in susceptible individuals due to its high sequence homology with the human homologue, as hypothesized by Wick et al. [15]. Indeed, circulating hsp65 antibodies are absent in specific pathogen-free animals. Likewise, Prohaszka et al. [12] confirmed the association of anti-H.pylori antibodies with antibacterial hsp65 or GroEL antibodies in humans, suggesting that induction of hsp65 antibodies primarily depends on infections. On the other hand, Prohaszka et al. [12] demonstrated that autoantibodies against human hsp60 are independent of H.pylori infections and weakly correlated with the presence of antibodies to bacterial hsp65 or GroEL. They also found that autoantibodies to human hsp60 and antibodies to mycobacterial hsp65 present in the sera of patients with atherosclerosis have different epitope specificity and complement activating ability [16]. According to this hypothesis, the production and the pathogenic involvement of antibacterial hsp65 antibodies and antihuman hsp60 autoantibodies in atherosclerosis are different. Support for this notion is the coexistance of circulating soluble hsp60 antigen and antimycobacterial hsp65 antibodies in subjects with atherosclerosis [17], indicating that these antibodies may not bind to soluble hsp60 in circulation. However, Western blot analysis provided solid evidence that antimycobacterial hsp65 antibodies did bind to human hsp60 [18]. The contradictory phenomena observed in vivo and in vitro might reflect the difference between native and denatured hsp60. Schett et al. [19] demonstrated that antimycobacterial hsp65 antibodies mediate endothelial cytotoxicity via cross-reactivity to human hsp60, implicating that endothelial cell injury might be induced in vivo[15]. If autoantibodies to human hsp60 are also a predictive parameter for atherosclerosis and independently exist in patients with severe atherosclerosis, it would be interesting to further study the mechanisms of the autoantibody production and how they are involved in the pathogenesis of atherosclerosis. I believe that search for the answer of these questions could enhance our understanding of the pathophysiology of atherosclerosis. During the process of the manuscript, a similar study showing an association of anti-human hsp60 antibodies and coronary artery disease has been published in Circulation 2001; 103: 1071–1075.

Role of Antiheat Shock Protein 60 Autoantibodies in Atherosclerosis.

Anti–Heat Shock Protein 60 Autoantibodies Induce Atherosclerosis in Apolipoprotein E–Deficient Mice Via Endothelial Damage

Autoimmune mechanisms of atherosclerosis.

Role Of Heat-Shock-Protein-65/60 In The Pathogenesis Of Atherosclerosis

Heat Shock Proteins and Atherosclerosis

Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity.

Autoimmune and inflammatory mechanisms in atherosclerosis.

Serum Soluble Heat Shock Protein 60 is Elevated in Subjects with Atherosclerosis in A General Population

Molecular chaperones and heat shock proteins in atherosclerosis

Atherosclerosis—An Autoimmune Disease! 11this Paper is a Modified Version of an Informal Article That Appeared in the February 1999 Issue of Immunology News of the British Society for Immunology.

Pathogenic Autoimmunity in Atherosclerosis Evolves from HSP60-Reactive CD4 + T Cells

Immune-mediated Mechanisms of Endothelial Damage in Atherosclerosis

Atherosclerosis: Beyond the lipid storage hypothesis. The role of autoimmunity

Cross-Reactive B-Cell Epitopes Of Microbial And Human Heat Shock Protein 60/65 In Atherosclerosis

Epitope Specificity Of Anti-Heat Shock Protein 65/60 Serum Antibodies In Atherosclerosis

IMMUNOLOGY OF ATHEROSCLEROSIS - DEMONSTRATION OF HEAT-SHOCK PROTEIN-60 EXPRESSION AND T-LYMPHOCYTES BEARING ALPHA/BETA OR GAMMA/DELTA RECEPTOR IN HUMAN ATHEROSCLEROTIC LESIONS

Association of Serum-Soluble Heat Shock Protein 60 with Carotid Atherosclerosis

Staining of Endothelial Cells and Macrophages in Atherosclerotic Lesions with Human Heat-Shock Protein-Reactive Antisera.

A Th2 immune shift to heat shock protein 65 fails to arrest atherosclerosis: Proatherogenic role of Th2-deviated autoantibodies.

Fluid Shear Stress Induces Heat Shock Protein 60 Expression in Endothelial Cells in Vitro and in Vivo